4 results about "Zymosan" patented technology

The invention discloses a preparation method of tea-aroma yellow rice wine, and belongs to the technical field of wine brewing. The method comprises the following steps: respectively crushing white hyacinth bean flower, fructus piperis longi and tea leaves; glutinous rice and lactic acid bacteria are added into water for rice soaking; steaming the rice, cooling the glutinous rice to 50 DEG C, adding the white hyacinth bean flower powder, and continuously cooling to 35 DEG C; putting materials into a vat, namely uniformly stirring and mixing water, a white hyacinth bean flower-rice mixture, wheat koji, distiller's yeast and cellulase; performing primary fermentation after feeding, during the primary fermentation period, performing primary raking 8-12h after primary fermentation, then performing timed raking, performing primary fermentation for four times, and adding zymosan for fermentation during third raking; cooling the fermented mash after pre-fermentation, performing post-fermentation, and adding tea powder and fructus piperis longi powder in stages during the post-fermentation period; and after post-fermentation, squeezing, centrifuging and sterilizing the fermentation liquor to obtain the tea-aroma yellow wine. The yellow rice wine disclosed by the invention is sweet and mellow in vinosity, pleasant in fragrance and good in mouth feel, and has tea fragrance, and the bioavailability and flavor quality of theaflavin in the tea-fragrance yellow rice wine are remarkably improved.

Compositions and methods for treating cancer, particularly leukemia, using a cytotoxic composition comprising monocytes activated by-glucan. The monocytes are preferably incubated with the β-glucan and then processed to extract particles, such as microvesicles and exosomes from the treated monocytes to produce the cytotoxic composition. Preferably the cytotoxic composition comprises at least 50% exosomes having a size of 150 nm or less that are activated with β-glucan. Zymosan is the preferred β-glucan. The cytotoxic composition has an apoptosis effect. When a subject having cancer is treated according to preferred embodiments, the cytotoxic composition preferably induces a cytokine response in the subject's immune system. The combination of the cytotoxic composition and cytokine response are synergistic.

This invention discloses a composition containing myxobin and zinc hyaluronic acid and its application. The present invention combines myxobin and zinc hyaluronic acid in a specific ratio, which, when used alone, has a better effect on reducing DHT damage to hair follicles and also better promotes hair follicle angiogenesis, exhibiting a synergistic effect on hair growth and hair loss prevention.

The present application relates to the field of food or medicine technology, and in particular to a zymopolysaccharide soft capsule shell, a preparation method and application thereof. The shell can effectively improve the stability problems of the soft capsule product, such as adhesion, oil leakage and hardening of the shell, which are prone to occur during the shelf life, and has a more excellent protective effect on the active ingredients of the environment-sensitive content. At the same time, the raw material cost is low, the preparation process is simple, and the shell has a broad application prospect in the fields of food, medicine and cosmetics.